发明名称 PHARMACEUTICAL COMPOSITION COMPRISING NITROGENATED FUSED CYCLIC COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition which is effective for the treatment or prevention of a disease associated with uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urinary calculus, renal dysfunction, coronary disorder and ischemic heart disease, and which has excellent long-term stability and elution properties (disintegration properties). SOLUTION: The pharmaceutical composition comprises a nitrogenated fused cyclic compound represented by general formula [1] (wherein each symbol is defined specifically) or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable additive, wherein the nitrogenated fused cyclic compound or the pharmaceutically acceptable salt thereof is not coming into contact with a basic additive. COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008056702(A) 申请公布日期 2008.03.13
申请号 JP20070297918 申请日期 2007.11.16
申请人 JAPAN TOBACCO INC 发明人 MIKI KAZUMOTO;ARIMOTO FUYUKI;SUNAMI MASAKI
分类号 A61K31/553;A61K9/28;A61K47/02;A61K47/38;A61P9/10;A61P13/04;A61P13/12;A61P19/02;A61P19/06;A61P43/00;C07D265/36 主分类号 A61K31/553
代理机构 代理人
主权项
地址